Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Precision Biologics Inc.

www.precision-biologics.com

Latest From Precision Biologics Inc.

Start-Up Quarterly Statistics, Q4 2015

Start-ups raised $2.41 billion in Q4 2015. Biopharma companies penned 29 alliances; seven acquisitions were signed in the biopharma and diagnostics industries.

BioPharmaceutical Medical Device

Obama’s Legacy Agenda: Curing Cancer, HIV, Malaria and Addiction – Not Capping Prices

The Administration is actively considering policy options to address prescription drug costs. But the President doesn’t want to be remembered for that.

BioPharmaceutical United States

Obama’s Legacy Agenda: Curing Cancer, HIV, Malaria and Addiction – Not Capping Prices

The Obama Administration is actively considering policy options to address prescription drug costs. But the President doesn’t want to be remembered for that.

BioPharmaceutical Reimbursement

Deals Shaping The Medical Industry, November 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced October 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Precision Biologics Inc.
  • Senior Management
  • Philip M Arlen, MD, CEO & CMO
  • Contact Info
  • Precision Biologics Inc.
    Phone: (214) 696-9766
    5910 N. Central Expwy.
    Ste. 1300
    Dallas, TX 75206
    USA
UsernamePublicRestriction

Register